M
Marinomed Biotech AG
VSE:MARI
Marinomed Biotech AG
VSE:MARI
Price:
13.9
EUR
-0.71%
Market Closed
Market Cap:
€25.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Marinomed Biotech AG
VSE:MARI
|
AT |
Balance Sheet
Balance Sheet Decomposition
Marinomed Biotech AG
Marinomed Biotech AG
Balance Sheet Decomposition is not available for
Marinomed Biotech AG
Marinomed Biotech AG
Balance Sheet
Marinomed Biotech AG
Marinomed Biotech AG
Currency: EUR
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
2
|
6
|
2
|
12
|
9
|
6
|
8
|
3
|
2
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
6
|
8
|
3
|
2
|
|
| Cash Equivalents |
2
|
6
|
2
|
12
|
9
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
2
|
2
|
3
|
5
|
5
|
3
|
2
|
1
|
|
| Accounts Receivables |
1
|
1
|
1
|
1
|
2
|
3
|
1
|
1
|
0
|
|
| Other Receivables |
1
|
0
|
1
|
2
|
3
|
1
|
2
|
1
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Total Current Assets |
3
|
8
|
4
|
15
|
15
|
13
|
14
|
7
|
3
|
|
| PP&E Net |
0
|
0
|
0
|
2
|
6
|
6
|
6
|
6
|
5
|
|
| PP&E Gross |
0
|
0
|
0
|
2
|
6
|
6
|
6
|
6
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
0
|
|
| Intangible Assets |
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
5
N/A
|
9
+89%
|
5
-44%
|
20
+271%
|
24
+21%
|
21
-9%
|
22
+4%
|
15
-34%
|
8
-44%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
0
|
1
|
2
|
1
|
2
|
2
|
1
|
2
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
5
|
4
|
0
|
0
|
1
|
2
|
7
|
0
|
|
| Other Current Liabilities |
1
|
1
|
2
|
3
|
3
|
3
|
2
|
1
|
3
|
|
| Total Current Liabilities |
4
|
7
|
8
|
4
|
6
|
6
|
6
|
10
|
5
|
|
| Long-Term Debt |
4
|
6
|
7
|
5
|
12
|
15
|
20
|
15
|
28
|
|
| Other Liabilities |
0
|
1
|
7
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Liabilities |
8
N/A
|
14
+90%
|
22
+50%
|
9
-60%
|
18
+110%
|
21
+17%
|
26
+25%
|
25
-6%
|
34
+39%
|
|
| Equity | ||||||||||
| Common Stock |
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
|
| Retained Earnings |
3
|
5
|
17
|
9
|
4
|
1
|
6
|
12
|
43
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
71
|
|
| Total Equity |
3
N/A
|
5
-90%
|
16
-224%
|
11
N/A
|
5
-51%
|
0
-96%
|
4
N/A
|
10
-144%
|
26
-158%
|
|
| Total Liabilities & Equity |
5
N/A
|
9
+89%
|
5
-44%
|
20
+271%
|
24
+21%
|
21
-9%
|
22
+4%
|
15
-34%
|
8
-44%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
|
Switch to:
Switch to:
See Also
Discover More
